Levine GN et al (2022) Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation 146(15):e205–e223
Ibanez B et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177
Vandvik PO et al (2012) Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e637S-e668S
Article CAS PubMed PubMed Central Google Scholar
Mehrpooya M, Barakzehi MR, Nikoobakhsh M (2024) Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left-ventricular thrombosis. A systematic review and meta-analysis. Heart Lung 67:121–136
Kosum P et al (2024) Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin. Sci Rep 14(1):11647
Article CAS PubMed PubMed Central Google Scholar
Maniwa N et al (2018) Anticoagulation combined with antiplatelet therapy in patients with left-ventricular thrombus after first acute myocardial infarction. Eur Heart J 39(3):201–208
Article CAS PubMed Google Scholar
van Leeuwen Y, Rosendaal FR, Cannegieter SC (2008) Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants. J Thromb Haemost 6(3):451–456
Zhou Y et al (2024) Direct oral anticoagulants compared with warfarin in patients with left-ventricular thrombus: a cohort study from China. J Thorac Dis 16(2):884–892
Article PubMed PubMed Central Google Scholar
Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis. 2003 Jun;15(3):213-6. https://doi.org/10.1023/B:THRO.0000011377.78585.63. PMID: 14739631.
Schulman S et al (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692–694
Article CAS PubMed Google Scholar
Kaatz S et al (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13(11):2119–2126
Article CAS PubMed Google Scholar
Valeriani E et al (2025) Long-term left-ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study. Intern Emerg Med 20(4):1069–1076
Article PubMed PubMed Central Google Scholar
Byrne RA et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720–3826
Article CAS PubMed Google Scholar
Lopes RD et al (2019) Safety and Efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials. JAMA Cardiol 4(8):747–755
Article PubMed PubMed Central Google Scholar
Di Odoardo LAF et al (2024) Left ventricular thrombus management after acute myocardial infarction in clinical practice: results from LEVITATION survey and narrative review. Cardiovasc Drugs Ther 38(3):483–492
Shi B et al (2023) Time trends of etiology, treatment, and long-term outcomes among patients with left ventricular thrombus. Rev Cardiovasc Med 24(10):298
Article PubMed PubMed Central Google Scholar
Tosetto A et al (2015) Center-related determinants of VKA anticoagulation quality: a prospective, multicenter evaluation. PLoS ONE 10(12):e0144314
Article PubMed PubMed Central Google Scholar
Kim YK et al (2010) Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. J Thromb Haemost 8(1):101–106
Article CAS PubMed Google Scholar
Van Spall HG et al (2012) Variation in warfarin dose-adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation 126(19):2309–2316
Article CAS PubMed Google Scholar
Erkens PM et al (2012) Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS ONE 7(9):e42269
Article CAS PubMed PubMed Central Google Scholar
Fujino M et al (2024) Comparison of embolic risk in left-ventricular thrombus between nonischemic and ischemic cardiomyopathy: a nationwide database analysis. Int J Cardiol 411:132329
Salah Shabib Ahmed H et al (2022) Surrogates of the left ventricular thrombus resolution: a retrospective data review. Arch Turk Soc Cardiol 50(3):168–174
Lattuca B et al (2020) Antithrombotic therapy for patients with left ventricular mural thrombus. J Am Coll Cardiol 75(14):1676–1685
Comments (0)